Free Trial

Abeona Therapeutics (ABEO) Short Interest Ratio & Short Volume

Abeona Therapeutics logo
$5.60 -0.11 (-1.91%)
As of 03:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Abeona Therapeutics Short Interest Overview

As of April 30, 2026, Abeona Therapeutics (ABEO) had a short interest of 16.49 million shares sold short, representing 30.64% of the public float. This marks a 0.10% increase in short interest since the prior report. The short interest ratio (days to cover) is 22.5, meaning it would take 22.5 days of the average trading volume of 1.21 million shares to cover all short positions.

Current Short Interest
16,486,060 shares
Previous Short Interest
16,470,051 shares
Change Vs. Previous Month
0.10%
Dollar Volume Sold Short
$90.01 million
Short Interest Ratio
22.5 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
56,883,000 shares
Short Percent of Float
30.64%
Today's Trading Volume
1,307,913 shares
Average Trading Volume
1,210,162 shares
Today's Volume Vs. Average
108%
Short Selling Abeona Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Abeona Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ABEO Short Interest Over Time

ABEO Days to Cover Over Time

ABEO Percentage of Float Shorted Over Time

Abeona Therapeutics Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202616,486,060 shares $90.01 million +0.1%30.6%22.53 $5.46
4/15/202616,470,051 shares $88.94 million +4.0%31.1%13.53 $5.40
3/31/202615,844,414 shares $70.98 million +4.9%29.8%9.6 $4.48
3/13/202615,098,544 shares $71.87 million +15.7%28.0%11.76 $4.76
2/27/202613,051,436 shares $66.82 million -4.7%25.5%15.22 $5.12
2/13/202613,687,867 shares $68.58 million -4.5%26.7%14.31 $5.01
1/30/202614,334,647 shares $72.96 million +3.7%28.0%10.36 $5.09
1/15/202613,819,258 shares $75.31 million +4.3%27.0%11.76 $5.45
12/31/202513,246,847 shares $69.81 million -5.4%25.8%14.03 $5.27
12/15/202513,998,273 shares $71.11 million +1.4%27.3%10.22 $5.08
11/28/202513,812,286 shares $69.89 million +1.6%26.9%8.04 $5.06
11/14/202513,589,078 shares $60.47 million +31.3%28.5%3.91 $4.45
10/31/202510,350,316 shares $49.79 million +12.7%21.7%6.35 $4.81
10/15/20259,190,000 shares $50.82 million +6.5%20.1%10.7 $5.53
9/30/20258,630,000 shares $45.57 million -1.2%18.9%10.6 $5.28
9/15/20258,730,000 shares $49.94 million -3.3%19.1%9.8 $5.72
8/31/20259,030,000 shares $61.67 million +2.5%19.8%11 $6.83
8/15/20258,810,000 shares $62.82 million +4.6%19.3%9.9 $7.13
7/31/20258,420,000 shares $53.64 million -0.7%18.5%8 $6.37
7/15/20258,480,000 shares $50.46 million +2.3%18.7%4.8 $5.95
6/30/20258,290,000 shares $47.09 million +28.3%18.3%4.6 $5.68
6/15/20256,460,000 shares $39.79 million +7.5%14.3%3.8 $6.16
5/31/20256,010,000 shares $36.90 million +2.0%13.3%3.7 $6.14
5/15/20255,890,000 shares $34.10 million +8.1%13.0%3.8 $5.79
4/30/20255,450,000 shares $35.75 million +97.5%12.6%4.3 $6.56
4/15/20252,760,000 shares $13.58 million +24.9%6.4%5 $4.92
3/31/20252,210,000 shares $10.52 million -7.5%5.2%5.2 $4.76
3/15/20252,390,000 shares $12.64 million -5.2%5.6%7.6 $5.29
2/28/20252,520,000 shares $13.20 million +2.0%6.6%9.3 $5.24
2/15/20252,470,000 shares $14.87 million -0.4%6.4%9.6 $6.02
1/31/20252,480,000 shares $13.74 million -6.8%6.5%9.1 $5.54
1/15/20252,660,000 shares $14.10 million +4.3%6.9%9.7 $5.30
12/31/20242,550,000 shares $14.20 million +0.8%6.5%10.1 $5.57
12/15/20242,530,000 shares $14.90 million -1.9%6.4%9.6 $5.89
11/30/20242,580,000 shares $16.49 million -1.9%6.6%9.6 $6.39
11/15/20242,630,000 shares $15.41 million -0.4%6.7%10.1 $5.86
10/31/20242,640,000 shares $16.92 million -4.7%6.7%10.6 $6.41
10/15/20242,770,000 shares $18.12 million +3.8%7.1%10.7 $6.54
9/30/20242,670,000 shares $16.87 million +1.5%6.8%8.9 $6.32
9/15/20242,630,000 shares $14.68 million -7.4%6.7%8.7 $5.58
I’m sounding the alarm (Ad)

Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.tc pixel

Watch Stansberry's full investigation and see which companies to buy and sell
8/31/20242,840,000 shares $16.19 million -6.3%7.3%8.2 $5.70
8/15/20243,030,000 shares $15.15 million +2.0%7.8%7.5 $5.00
7/31/20242,970,000 shares $14.55 million -3.6%7.7%6.5 $4.90
7/15/20243,080,000 shares $16.60 million -8.3%8.0%4 $5.39
6/30/20243,360,000 shares $14.25 million +26.8%8.5%4.6 $4.24
6/15/20242,650,000 shares $12.11 million +15.7%6.7%3.7 $4.57
5/31/20242,290,000 shares $10.03 million -24.2%5.8%3.2 $4.38
5/15/20243,020,000 shares $14.22 million -9.9%7.8%4.3 $4.71
4/30/20243,350,000 shares $13.87 million +62.6%12.9%5 $4.14
4/15/20242,060,000 shares $15.74 million +3.5%8.0%4.3 $7.64
3/31/20241,990,000 shares $14.43 million +17.1%7.7%6 $7.25
3/15/20241,700,000 shares $14.67 million +3.7%6.6%4.8 $8.63
2/29/20241,640,000 shares $11.32 million +5.1%7.0%5.4 $6.90
2/15/20241,560,000 shares $10.12 million +100.4%6.7%5.4 $6.49
1/31/2024778,500 shares $3.17 million +17.6%3.3%3.5 $4.07
1/15/2024662,100 shares $3.48 million +9.6%2.8%3.6 $5.25
12/31/2023603,900 shares $3.03 million +40.7%2.6%3.4 $5.01
12/15/2023429,200 shares $2.09 million -21.8%1.8%2.5 $4.87
11/30/2023549,000 shares $2.64 million -9.1%2.4%3.8 $4.80
11/15/2023603,700 shares $2.51 million -4.2%2.6%5.6 $4.15
10/31/2023630,400 shares $2.41 million +1.9%2.8%5.6 $3.82
10/15/2023618,500 shares $2.56 million 0.0%2.8%4.9 $4.14
9/30/2023618,700 shares $2.60 million +2.9%2.8%4.5 $4.21
9/15/2023601,400 shares $2.42 million +20.2%2.7%4.3 $4.03
8/31/2023500,500 shares $2.22 million +13.2%2.2%3 $4.43
8/15/2023442,000 shares $1.52 million -17.8%1.9%2.4 $3.45
7/31/2023538,000 shares $1.84 million -27.5%2.6%3.1 $3.42
7/15/2023742,500 shares $2.88 million +38.6%3.6%4.4 $3.88
6/30/2023535,900 shares $2.16 million +13.7%2.6%3.3 $4.03
6/15/2023471,400 shares $2.12 million +8.5%2.7%3 $4.49
5/31/2023434,500 shares $1.34 million +18.5%2.4%3 $3.09
5/15/2023366,600 shares $1.13 million -28.4%2.0%2.6 $3.08
4/30/2023512,300 shares $1.57 million -14.8%3.0%3.5 $3.07
4/15/2023601,000 shares $1.68 million -19.9%3.5%3.8 $2.79
3/31/2023750,500 shares $2.12 million +24.2%4.4%4.1 $2.82
3/15/2023604,400 shares $1.58 million +31.3%3.6%2.6 $2.62
2/28/2023460,500 shares $1.05 million +6.7%2.8%1.9 $2.29
2/15/2023431,600 shares $1.03 million -17.7%2.6%1.8 $2.38
1/31/2023524,300 shares $1.32 million -28.2%3.2%1.7 $2.52
1/15/2023730,200 shares $1.94 million -29.1%4.4%1.8 $2.65
12/30/20221,030,000 shares $3.17 million -4.6%6.2%2 $3.08
12/15/20221,080,000 shares $3.08 million +4.9%6.5%2.1 $2.85
11/30/20221,030,000 shares $3.87 million -3.7%6.2%2.1 $3.76
11/15/20221,070,000 shares $4.32 million +47.7%6.6%2.3 $4.04
10/31/2022724,600 shares $3.33 million +19.3%14.7%1.6 $4.59
10/15/2022607,300 shares $2.61 million +138.5%12.3%1.6 $4.30
9/30/2022254,600 shares $773.98 thousand +43.4%5.2%0.9 $3.04
9/15/2022177,500 shares $722.43 thousand -9.0%3.3%1 $4.07
8/31/2022195,100 shares $710.16 thousand -25.8%3.6%1.1 $3.64
8/15/2022263,000 shares $1.22 million +25.2%4.9%1.6 $4.65
I’m sounding the alarm (Ad)

Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.tc pixel

Watch Stansberry's full investigation and see which companies to buy and sell
7/31/2022210,100 shares $832.00 thousand -1.4%3.9%1.6 $3.96
7/15/2022213,100 shares $1.03 million +13.7%4.0%2 $4.85
6/30/2022187,500 shares $975.00 thousand -96.3%3.5%2 $5.20
6/15/20225,070,000 shares $819.82 thousand +17.4%N/A2.7 $0.16
5/31/20224,320,000 shares $725.76 thousand -1.8%N/A2.4 $0.17
5/15/20224,400,000 shares $712.36 thousand +8.9%N/A2.2 $0.16
4/30/20224,040,000 shares $834.26 thousand -13.3%N/A2.1 $0.21
4/15/20224,660,000 shares $1.27 million +18.3%N/A2.4 $0.27
3/31/20223,940,000 shares $1.24 million -2.5%N/A1.8 $0.32
3/15/20224,040,000 shares $1.04 million +9.5%N/A1.4 $0.26
2/28/20223,690,000 shares $952.02 thousand -21.0%N/A1 $0.26
2/15/20224,670,000 shares $1.25 million -7.9%N/A1.3 $0.27
1/31/20225,070,000 shares $1.29 million +242.6%N/A1.5 $0.26
1/15/20221,480,000 shares $404.04 thousand +13.9%N/A0.5 $0.27
12/31/20211,300,000 shares $438.10 thousand -3.0%N/A0.5 $0.34
12/15/20211,340,000 shares $698.14 thousand +47.8%1.5%0.6 $0.52
11/30/2021906,400 shares $624.51 thousand -57.0%1.0%1.2 $0.69
11/15/20212,110,000 shares $1.92 million -20.7%2.4%3 $0.91
10/29/20212,660,000 shares $2.16 million -8.3%3.1%4 $0.81
10/15/20212,900,000 shares $2.64 million +2.1%3.3%4.4 $0.91
9/30/20212,840,000 shares $3.18 million -12.4%3.3%3.4 $1.12
9/15/20213,240,000 shares $4.02 million -13.8%3.7%3.3 $1.24
8/31/20213,760,000 shares $4.96 million -18.3%4.3%3.4 $1.32
8/13/20214,600,000 shares $5.66 million -2.5%5.3%3.6 $1.23
7/30/20214,720,000 shares $5.76 million -1.1%5.4%3.3 $1.22
7/15/20214,770,000 shares $6.44 million +16.9%5.5%3.2 $1.35
6/30/20214,080,000 shares $6.36 million -34.4%4.8%2.6 $1.56
6/15/20216,220,000 shares $10.45 million -6.5%7.2%4 $1.68
5/28/20216,650,000 shares $10.97 million -14.6%7.7%4.1 $1.65
5/14/20217,790,000 shares $10.05 million +24.8%N/A3.3 $1.29

ABEO Short Interest - Frequently Asked Questions

Short interest is the volume of Abeona Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 16,486,060 shares of ABEO short. 30.64% of Abeona Therapeutics' shares are currently sold short. Learn More on Abeona Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABEO shares currently have a short interest ratio of 22.5. Learn More on Abeona Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abeona Therapeutics: Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 30.64% of Abeona Therapeutics' floating shares are currently sold short.

Abeona Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 16,486,060 shares, an increase of 0.1% from the previous total of 16,470,051 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

30.64% of Abeona Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Abeona Therapeutics: uniQure N.V. (17.96%), MoonLake Immunotherapeutics (10.02%), Pharming Group N.V. Sponsored ADR (0.01%), Jade Biosciences, Inc. (8.15%), Compass Pathways PLC Sponsored ADR (7.80%), Urogen Pharma (15.59%), Collegium Pharmaceutical, Inc. (18.65%), DBV Technologies S.A. (3.31%), Evotec AG (0.02%), Xeris Biopharma Holdings, Inc. (9.65%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling ABEO is an investing strategy that aims to generate trading profit from Abeona Therapeutics as its price is falling. ABEO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Abeona Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABEO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABEO, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ABEO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:ABEO) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners